全球肌萎缩侧索硬化症 (ALS) 市场 - 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球肌萎缩侧索硬化症 (ALS) 市场 - 行业趋势和 2029 年预测

  • Pharmaceutical
  • Upcoming Report
  • Jan 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

>全球肌萎缩侧索硬化症 (ALS) 市场,按类型(散发性 ALS、家族性 ALS)、治疗类型(化疗、药物、干细胞治疗、物理治疗、呼吸治疗、言语治疗、其他)、诊断(肌电图、MRI、血液和尿液测试、脊椎穿刺、肌肉活检)、症状(认知变化、疼痛、言语不清、疲劳、呼吸困难和吞咽唾液和粘液问题、笨拙增加、痉挛和抽搐、虚弱、难以保持良好姿势、其他)、最终用户(诊所、医院、其他)、分销渠道(医院药房、零售药房、网上药房)、国家(美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区)行业趋势和预测至 2029 年

肌萎缩侧索硬化症 (ALS) 市场

市场分析和洞察全球肌萎缩侧索硬化症 (ALS) 市场

肌萎缩侧索硬化症 (ALS) 市场预计将在 2022-2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称,在上述预测期内,市场复合年增长率将达到 6.13%。

肌萎缩侧索硬化症 (ALS) 也被称为卢格里格氏症。这是一种渐进性神经退行性疾病,中枢神经系统中调节随意肌的神经细胞受到损害。肌肉抽搐、肌肉僵硬和由于腿部或手臂肌肉尺寸减小而导致的虚弱是这种疾病的一些常见症状。最常见的运动神经元疾病类型是 ALS,它会导致身体细胞退化和死亡,使大脑无法调节随意运动。大约一半的 ALS 患者可能会失去吞咽、呼吸、说话、行走和使用双手的能力。

The rise in the prevalence of amyotrophic lateral sclerosis will act as major driver that will results in the expansion of market’s growth. Another significant factor influencing the growth rate of amyotrophic lateral sclerosis (ALS) market is the rising healthcare expenditure. Furthermore, advancement in the medical technology, rising initiatives by public and private organisations to spread awareness and growing government funding are the factors that will expand the amyotrophic lateral sclerosis (ALS) market. Other factors such as increase in the demand for effective therapies and rising geriatric population will positively impact the amyotrophic lateral sclerosis (ALS) market’s growth rate. Additionally, high disposable income and inclination towards sedentary lifestyle will result in the expansion of amyotrophic lateral sclerosis (ALS) market.

Moreover, the rise in the research and development activities and launch of effective therapies will provide beneficial opportunities for the amyotrophic lateral sclerosis (ALS) market in the forecast period of 2022-2029. Also, high unmet need of current treatment and developments in healthcare technology will escalate the growth rate amyotrophic lateral sclerosis (ALS) market in future.

However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of amyotrophic lateral sclerosis (ALS) market. Additionally, complications involved with the disease will hinder the amyotrophic lateral sclerosis (ALS) market growth. Less awareness and the dearth of technically skilled professionals will further challenge the market in the forecast period mentioned above.

This amyotrophic lateral sclerosis (ALS) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Amyotrophic lateral sclerosis (ALS) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Amyotrophic Lateral Sclerosis (ALS) Market Scope and Market Size

The amyotrophic lateral sclerosis (ALS) market is segmented on the basis of type, treatment type, diagnosis, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • 根据类型,肌萎缩侧索硬化症治疗市场可分为散发性 ALS 和家族性 ALS。
  • 根据治疗类型,肌萎缩侧索硬化症治疗市场可细分为化疗、药物治疗、干细胞治疗、物理治疗、呼吸治疗、言语治疗和其他治疗。药物治疗细分又细分为利鲁唑、依达拉奉和 Nuedexta。
  • 根据诊断,肌萎缩侧索硬化症治疗市场可细分为肌电图、核磁共振成像、血液和尿液测试、脊椎穿刺、肌肉活检。
  • 根据症状,肌萎缩侧索硬化症治疗市场可细分为认知变化、疼痛、言语不清、疲劳、呼吸困难、唾液和粘液吞咽问题、笨拙增加、痉挛和抽搐、虚弱、难以保持良好姿势等
  • 根据最终用户,肌萎缩侧索硬化症 (ALS) 市场分为诊所、医院和其他。
  • 肌萎缩侧索硬化症 (ALS) 市场还根据分销渠道细分为医院药房、零售药房和网上药房。

肌萎缩侧索硬化症 (ALS) 市场国家级分析

对肌萎缩侧索硬化症 (ALS) 市场进行分析,并按上述国家、类型、治疗类型、诊断、症状、最终用户和分销渠道提供市场规模信息。

肌萎缩侧索硬化症 (ALS) 市场报告涉及的国家 包括美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区。

北美在肌萎缩侧索硬化症 (ALS) 市场占据主导地位,因为该地区拥有主要关键参与者、优惠的报销政策和发达的医疗保健基础设施。由于患者人数不断增加、医疗保健行业投资不断增加以及政府支持不断增加,预计亚太地区将在 2022-2029 年预测期内实现增长。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化,这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。

患者流行病学分析

肌萎缩侧索硬化症 (ALS) 市场还为您提供详细的市场分析,包括患者分析、预后和治疗。患病率、发病率、死亡率、依从率是报告中提供的一些数据变量。分析流行病学对市场增长的直接或间接影响,以创建更稳健、更全面的多元统计模型,用于预测增长期的市场。

竞争格局和全球肌萎缩侧索硬化症 (ALS) 市场份额分析

肌萎缩侧索硬化症 (ALS) 市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对肌萎缩侧索硬化症 (ALS) 市场研究的关注有关。

肌萎缩侧索硬化症 (ALS) 市场的一些主要参与者包括 Orion Corporation、Bausch Health Companies Inc.、CYTOKINETICS, INC.、Aquestive Therapeutics, Inc.、Sanofi、Covis Pharma、Sun Pharmaceuticals Industries Ltd、Mitsubishi Tanabe Pharma Corporation、BrainStorm Cell Limited、ViroMed Co., Ltd、Ionis Pharmaceuticals、Genervon Biopharmaceuticals, LLC、Biogen、Orphazyme A/S、Apotex Inc、Neuralstem, Inc.、Implicit Bioscience、F. Hoffmann-La Roche Ltd、AB Science 和 ADVANZ PHARMA 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

North America dominates the amyotrophic lateral sclerosis (ALS) market due to the presence of major key players, favorable reimbursement policies and well-developed healthcare infrastructure in this region.
Type, treatment type, diagnosis, symptoms, end-users, and distribution channel are the factors on which the amyotrophic lateral sclerosis (ALS) market research is based.
The rise in the prevalence of amyotrophic lateral sclerosis & rising healthcare expenditure are the growth drivers of the amyotrophic lateral sclerosis (ALS) market.
The growth rate of the amyotrophic lateral sclerosis (ALS) market is 6.13% by 2029.
Major companies in the amyotrophic lateral sclerosis (ALS) market are in the amyotrophic lateral sclerosis (ALS) market are Orion Corporation, Bausch Health Companies Inc., CYTOKINETICS, INC., Aquestive Therapeutics, Inc., Sanofi, Covis Pharma, Sun Pharmaceuticals Industries Ltd, Mitsubishi Tanabe Pharma Corporation, BrainStorm Cell Limited, ViroMed Co., Ltd, Ionis Pharmaceuticals, Genervon Biopharmaceuticals, LLC, Biogen, Orphazyme A/S, Apotex Inc, Neuralstem, Inc., Implicit Bioscience, F. Hoffmann-La Roche Ltd, AB Science, and ADVANZ PHARMA, among others.